SVP and Chief Medical Officer Eyal C. Attar sold $62K of Aprea Therapeutics, Inc.

Sold$62,280

$1.73Price

36,000Shares

−43%Stake

What APRE did after the filing

Prices for APRE after this filing aren't in yet.

Traded Mon, Feb 28. Filed Tue, Mar 1, 12:01 PM ET, during the session. Not investment advice.